John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 10,000 shares at $9.73 ($98K) on 2011-03-11, disclosed to the SEC on 2011-03-14.
Open-market purchase of $98k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.73 | 1,101 | $11K | 10.9% |
| 2 | $9.73 | 3,899 | $38K | 38.7% |
| 3 | $9.88 | 600 | $6K | 6.0% |
| 4 | $9.88 | 700 | $7K | 7.1% |
| 5 | $9.88 | 3,700 | $37K | 37.3% |
| Total | $9.80 avg | 10,000 |
| $98K |
| 100% |
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| LGND | SELL | 2021-11-17 | $1.6M | — | Filing → |